Skip to main navigation
Skip to search
Skip to main content
Edge Hill University Home
Help & FAQ
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Prizes
Impacts
Equipment
Datasets
Search by expertise, name or affiliation
Intermittent prophylactic antibiotics for bronchiectasis
SALLY SPENCER
, Tim Donovan
, James Chalmers
, Alexander Mathioudakis
, Melissa McDonnell
, ANTHONY TSANG
, PETER LEADBETTER
Medical School
University of Cumbria
University of Dundee
University of Manchester
Saolta University Health Care Group
Research output
:
Contribution to journal
›
Article (journal)
›
peer-review
14
Citations (Scopus)
292
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intermittent prophylactic antibiotics for bronchiectasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Absence
11%
Adverse Event
100%
Allergic Bronchopulmonary Aspergillosis
11%
Aminoglycoside
11%
Antibiotic Agent
100%
Antibiotic Resistance
66%
Antibiotic Therapy
22%
Antibiotics
77%
Bronchiectasis
100%
Chest Infection
22%
Chronic Obstructive Lung Disease
11%
Ciliary Dyskinesia
11%
Ciprofloxacin
11%
Coughing
11%
Cystic Fibrosis
11%
Disease
11%
Immunoglobulin Deficiency
11%
Infection
22%
Inflammation
11%
Lactam
11%
Placebo
44%
Quinolone Derivative
22%
Randomized Controlled Trial
22%
Recurrent Infection
11%
Sarcoidosis
11%
Symptom
11%
Medicine and Dentistry
Absence
7%
Adverse Event
64%
Allergic Bronchopulmonary Aspergillosis
7%
Aminoglycoside
7%
Antibiotic Resistance
42%
Antibiotic Therapy
21%
Antibiotics
100%
Bronchiectasis
100%
Bronchography
7%
Chest Infection
14%
Chronic Disorder
7%
Chronic Obstructive Pulmonary Disease
7%
Ciprofloxacin
7%
Clinical Guideline
7%
Coughing
7%
Cystic Fibrosis
7%
Drug Megadose
7%
High-Resolution Computed Tomography
7%
Hypogammaglobulinemia
7%
Infection
14%
Lactam
7%
Odds Ratio
35%
Placebo
28%
Pooled Analysis
7%
Primary Ciliary Dyskinesia
7%
Quality of Life
35%
Quinolone Derivative
14%
Randomized Controlled Trial
14%
Recurrent Infection
7%
Sarcoidosis
7%
Symptom
7%
Thorax Radiography
7%
Keyphrases
Life Effects
25%
Recurrent Chest Infection
12%
Nursing and Health Professions
Aminoglycoside
11%
Lactam
11%